Dr. Katherine E. Burdick serves as Scientific Director for the Integrated Network for Breakthrough Discoveries for thriving with Bipolar Disorders (BD2). She is the Jonathan F. Borus, MD Distinguished Chair in Psychiatry and the VC for Research in Psychiatry at Brigham and Women’s Hospital in Boston, MA where she directs the Mood and Psychosis Research Program. She holds a rank of Professor at Harvard Medical School. She is also a member of the Board of Directors for the National Network of Depression Centers (NNDC), and the International Society for Bipolar Disorders (ISBD), and as a member of the scientific advisory board for the Depression and Bipolar Support Alliance (DBSA). Dr. Burdick’s work is focused on neurocognition, with a specific expertise in bipolar disorder (BD). One of the first in the field to acknowledge the presence of cognitive impairment in BD, she has dedicated the past two decades to investigating the clinical, biological, neuroimaging, genetic, and functional correlates of this phenomenon. Dr. Burdick’s work has also highlighted the need to target this domain directly with treatment to promote full recovery in every patient. She has published more than 165 articles and has received several awards for her work in this area, including the prestigious Colvin Prize for Outstanding Achievement in Mood Disorders Research from the Brain and Behavior Research Foundation in 2021 and the Klerman Award from the DBSA in 2023. She is also a dedicated mentor and hopes to help to cultivate the next generation of researchers in this field.